Skip to content
The Policy VaultThe Policy Vault

Lenvima (lenvatinib capsules) — Cigna

Thyroid Carcinoma, Medullary

Initial criteria

  • Patient is age ≥ 18 years
  • Patient has tried at least one systemic therapy

Approval duration

1 year